[Mechanism of constriction and dilatation of pulmonary artery induced by hydrogen peroxide].

Hydrogen peroxide (H2O2) is known to cause transient pulmonary vasoconstriction in isolated lungs perfused with a solution containing no blood components, by inducing vasoactive arachidonate metabolites such as thromboxane A2 (TXA2). However, the exact site of production of the vasoactive arachidonates in the lung tissue is unclear. Using isolated main pulmonary arterial rings obtained from male Sprague-Dawley rats (B.W. 300-350 g), we attempted to examine the arachidonate metabolism, especially that mediated by cyclooxygenase, in the vascular wall of pulmonary artery without endothelium. Changes in isometric tension were used to measure contraction or dilatation of the ring preparation. H2O2 caused transient contraction of the ring, which was treated previously with a solution containing a high concentration of potassium (20 mM). The contractile response was enhanced in parallel with the concentration of H2O2 in the presence or absence of endothelium. Catalase (1000 U/ml), a H2O2 scavenger, completely inhibited the response of the isolated ring (without endothelium) to H2O2. OKY-046 (10(-5) and 10(-4) M), a TXA2 synthetase blocker, partially attenuated the contractile response induced by H2O2. ONO-3708 (10(-5) M), a TXA2 and prostaglandin H2 receptor blocker, fully inhibited the vasoconstriction and caused relaxation of the ring without endothelium after addition of H2O2. Indomethacin (5 microM), a cyclooxygenase inactivator, completely inhibited both vasoconstriction and vasodilation of the denuded ring. H2O2 also induced the release of 6-keto-prostaglandin F1 alpha, a stable metabolite of the vasodilator, prostacyclin, from the pulmonary artery without endothelium.(ABSTRACT TRUNCATED AT 250 WORDS)

[1]  S. Matalon,et al.  Mechanisms of extracellular reactive oxygen species injury to the pulmonary microvasculature. , 1992, Journal of applied physiology.

[2]  M. Wolin,et al.  Hydrogen peroxide-induced pulmonary vasodilation: role of guanosine 3',5'-cyclic monophosphate. , 1991, The American journal of physiology.

[3]  T. Burke-Wolin,et al.  Interactions of oxidant stress and vascular reactivity. , 1991, The American journal of physiology.

[4]  Z. Terashita,et al.  Endothelin-1 and platelet activating factor stimulate thromboxane A2 biosynthesis in rat vascular smooth muscle cells. , 1990, Biochemical pharmacology.

[5]  J. Grose,et al.  Contractile effect of the chemotactic factors f-Met-Leu-Phe and C5a on the human isolated umbilical artery. Role of cyclooxygenase products and tissue macrophages. , 1990, Circulation research.

[6]  K. Okumura,et al.  Prostaglandin H2 may be the endothelium-derived contracting factor released by acetylcholine in the aorta of the rat. , 1990, Hypertension.

[7]  H. Imawaka,et al.  Effects of ONO-3708, an antagonist of the thromboxane A2/prostaglandin endoperoxide receptor, on blood vessels. , 1989, European journal of pharmacology.

[8]  J. Heffner,et al.  Pulmonary strategies of antioxidant defense. , 1989, The American review of respiratory disease.

[9]  D. Hocking,et al.  Protein kinase inhibitor prevents pulmonary edema in response to H2O2. , 1989, American Journal of Physiology.

[10]  J. Eaton,et al.  Oxygen radicals and antioxidant enzymes alter pulmonary vascular reactivity in the rat lung. , 1989, Journal of applied physiology.

[11]  M. Wolin,et al.  Hydrogen peroxide elicits pulmonary arterial relaxation and guanylate cyclase activation. , 1987, The American journal of physiology.

[12]  M. Friedman,et al.  Effect of hypoxia on prostacyclin production in cultured pulmonary artery endothelium. , 1986, Prostaglandins.

[13]  W. Seeger,et al.  The glutathione redox cycle as a defense system against hydrogen-peroxide-induced prostanoid formation and vasoconstriction in rabbit lungs. , 1986, The American review of respiratory disease.

[14]  L. Ignarro,et al.  Differences in responsiveness of intrapulmonary artery and vein to arachidonic acid: mechanism of arterial relaxation involves cyclic guanosine 3':5'-monophosphate and cyclic adenosine 3':5'-monophosphate. , 1985, The Journal of pharmacology and experimental therapeutics.

[15]  J. Repine,et al.  Oxygen metabolites stimulate thromboxane production and vasoconstriction in isolated saline-perfused rabbit lungs. , 1984, The Journal of clinical investigation.

[16]  S. Hamano,et al.  Effects of thromboxane synthetase inhibitors on aggregation of rabbit platelets. , 1983, European journal of pharmacology.

[17]  J. Salmon,et al.  Prostacyclin and thromboxane A2 synthesis by rabbit pulmonary artery. , 1980, The Journal of pharmacology and experimental therapeutics.

[18]  W. Smith Prostaglandin biosynthesis and its compartmentation in vascular smooth muscle and endothelial cells. , 1986, Annual review of physiology.